Orilanolimab Antibody
Orilanolimab (SYNT001, ALXN1830) is a humanized, deimmunized monoclonal antibody that inhibits the FcRn-IgG interaction. It is utilized in immunology research to investigate IgG-mediated autoimmune diseases, with applications in both in vitro binding assays and in vivo models of pathogenic antibody clearance.
Product Specifications
Product Name Alternative
Orilanolimab, ALXN 1830, ALXN1830, SYNT 001, SYNT001, SYNT-001
Target
Others
Clonality
Monoclonal
Conjugation
Unconjugated
Concentration
6.26 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.02 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682097-500 1x 500 µL
Human IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IgD26), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881671-500 1x 500 µL
Annexin A1 / (Hairy Cell Leukemia Marker) (ANXA1/1671), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
